Literature DB >> 1500500

Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae.

P M Roblin1, W Dumornay, M R Hammerschlag.   

Abstract

Chlamydia pneumoniae has proved to be difficult to isolate and propagate in cell culture. We compared the growth of three strains of C. pneumoniae, TW-183 and two clinical isolates from Brooklyn, N.Y., in five cell lines, including HeLa 229, McCoy, HL, HEp-2, and HTED, an immortalized human tracheal cell line. HEp-2 was the most sensitive cell line tested. When 10-fold dilutions of three C. pneumoniae strains at known titers were inoculated into the different cell lines, the mean number of inclusion-forming units per milliliter was 1 to 2 log units higher in the HEp-2 than in the other cell lines. This difference was statistically significant. Omission of pretreatment with DEAE-dextran resulted in larger inclusions than those seen in pretreated cells, with the exception of McCoy and HTED cells. Retrieval of clinical specimens previously cultured on HeLa 229 cells and comparison of mean inclusion counts in fresh clinical specimens simultaneously inoculated on HeLa 229 and HEp-2 cells suggested that culture in HEp-2 cells may require only the initial inoculation and one passage, compared with three to four passages, as required by culture in HeLa 229 cells.

Entities:  

Mesh:

Year:  1992        PMID: 1500500      PMCID: PMC265424          DOI: 10.1128/jcm.30.8.1968-1971.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  4 in total

1.  Use of HL cells for improved isolation and passage of Chlamydia pneumoniae.

Authors:  L D Cles; W E Stamm
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

2.  A sensitive cell line, HL cells, for isolation and propagation of Chlamydia pneumoniae strain TWAR.

Authors:  C C Kuo; J T Grayston
Journal:  J Infect Dis       Date:  1990-09       Impact factor: 5.226

Review 3.  A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR.

Authors:  J T Grayston; L A Campbell; C C Kuo; C H Mordhorst; P Saikku; D H Thom; S P Wang
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

4.  Factors affecting viability and growth in HeLa 229 cells of Chlamydia sp. strain TWAR.

Authors:  C C Kuo; J T Grayston
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948

  4 in total
  66 in total

1.  cDNA array analysis of altered gene expression in human endothelial cells in response to Chlamydia pneumoniae infection.

Authors:  B K Coombes; J B Mahony
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

2.  Is Chlamydia pneumoniae present in brain lesions of patients with multiple sclerosis?

Authors:  M R Hammerschlag; Z Ke; F Lu; P Roblin; J Boman; B Kalman
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

3.  Analytical sensitivity, reproducibility of results, and clinical performance of five PCR assays for detecting Chlamydia pneumoniae DNA in peripheral blood mononuclear cells.

Authors:  J B Mahony; S Chong; B K Coombes; M Smieja; A Petrich
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

4.  Evaluation of Chlamydia pneumoniae and Mycoplasma pneumoniae as etiologic agents of persistent cough in adolescents and adults.

Authors:  Robert M Wadowsky; Elias A Castilla; Stella Laus; Anita Kozy; Robert W Atchison; Lawrence A Kingsley; Joel I Ward; David P Greenberg
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

5.  Analysis of Chlamydia pneumoniae growth in cells by reverse transcription-PCR targeted to bacterial gene transcripts.

Authors:  Shusaku Haranaga; Hideaki Ikejima; Hiroyuki Yamaguchi; Herman Friedman; Yoshimasa Yamamoto
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

6.  Ultrastructural study of Chlamydia pneumoniae in a continuous-infection model.

Authors:  A Kutlin; C Flegg; D Stenzel; T Reznik; P M Roblin; S Mathews; P Timms; M R Hammerschlag
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

7.  The Role of Chlamydia in Upper Respiratory Tract Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-04       Impact factor: 3.725

8.  Effect of a Mycoplasma hominis-like Mycoplasma on the infection of HEp-2 cells by the TW-183 strain of Chlamydia pneumoniae.

Authors:  E A Castilla; R M Wadowsky
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

9.  Chlamydia pneumoniae resists antibiotics in lymphocytes.

Authors:  Hiroyuki Yamaguchi; Herman Friedman; Mayumi Yamamoto; Keigo Yasuda; Yoshimasa Yamamoto
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

10.  Comparison of a new quantitative ompA-based real-Time PCR TaqMan assay for detection of Chlamydia pneumoniae DNA in respiratory specimens with four conventional PCR assays.

Authors:  Petra Apfalter; Wolfgang Barousch; Marion Nehr; Athanasios Makristathis; Birgit Willinger; Manfred Rotter; Alexander M Hirschl
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.